Printer Friendly

STEVEN A. FLECKMAN APPOINTED TO BOARD OF APPLIED BIOSCIENCE INTERNATIONAL, INC.

 ARLINGTON, Va., March 26 /PRNewswire/ -- Grover C. Wrenn, president and CEO of Applied Bioscience International (NASDAQ: APBI) announced today the appointment of Steven A. Fleckman to the board of directors of the Arlington-based company. Mr. Fleckman is a partner in the Austin, Texas law firm, Fleckman Johnson & Passman. From 1983 through 1992 he served as Chief Legal Counsel for Pharmaco (now Pharmaco LSR), an APBI subsidiary, and the world's largest provider of toxicology and clinical drug development services. Mr. Fleckman is credited with playing an instrumental role in guiding and developing Pharmaco to its present position as an international leader in its industry.
 Mr. Fleckman received his J.D. from Harvard Law School in 1975. He currently serves on the Texas State Bar Committee on Intellectual Property Law. Active in the Austin community, Mr. Fleckman was recently chosen to be a member in the 1993 Class of Leadership, Austin.
 APBI provides a broad range of inter-related services, including biological safety testing and clinical research and development through its Life Sciences Group, and assessment and management of chemical and environmental risk, agrochemical research and development, and related analytical chemistry services through its Environmental Sciences Group. These services are provided under contract to clients in the pharmaceutical, general chemical, agrochemical, and other industries worldwide.
 -0- 3/26/93
 /CONTACT: John H. Timoney, senior vice president of Applied Bioscience International, 609-951-9090; or John J. McNamara of John McNamara Advertising, 212-509-7779, for Applied Bioscience International/
 (APBI)


CO: Applied Bioscience International Inc. ST: Virginia IN: MTC SU: PER

SH -- NY035 -- 9503 03/26/93 14:34 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 26, 1993
Words:262
Previous Article:ENNIS BUSINESS FORMS, INC. DECLARES QUARTERLY DIVIDEND AND SETS RECORD DATE FOR ANNUAL STOCKHOLDERS' MEETING
Next Article:KINARK ANNOUNCES APPOINTMENTS TO BOARD
Topics:


Related Articles
APPLIED BIOSCIENCE INTERNATIONAL ANNOUNCES ACQUISITION OF NATIONAL EXPRESS LABORATORIES
APPLIED BIOSCIENCE INTERNATIONAL APPOINTS TIMONEY SENIOR VICE PRESIDENT, AMUNDSEN CHIEF FINANCIAL OFFICER
APPLIED BIOSCIENCE INTERNATIONAL INC. ELECTS SWEP T. DAVIS TO BOARD OF DIRECTORS AND APPOINTS HIM PRESIDENT, ENVIRONMENTAL SCIENCES GROUP
APPLIED BIOSCIENCE INTERNATIONAL INC. ANNOUNCES STOCK REPURCHASE PROGRAM OF UP TO 1 MILLION SHARES OF COMMON STOCK
APPLIED BIOSCIENCE INTERNATIONAL INC. APPOINTS BRACKEN VICE PRESIDENT, MARKETING AND BUSINESS DEVELOPMENT, ENVIRONMENTAL SCIENCES GROUP

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters